Name | Number of supported studies | Average coverage | |
|---|---|---|---|
| oligodendrocyte precursor cell | 9 studies | 28% ± 11% | |
| retinal bipolar neuron | 5 studies | 41% ± 14% | |
| interneuron | 5 studies | 34% ± 20% | |
| GABAergic neuron | 4 studies | 31% ± 15% | |
| glutamatergic neuron | 4 studies | 43% ± 8% | |
| OFF-bipolar cell | 3 studies | 33% ± 9% | |
| ON-bipolar cell | 3 studies | 21% ± 4% | |
| rod bipolar cell | 3 studies | 83% ± 7% |
Name | Number of supported studies | Average coverage | |
|---|---|---|---|
| brain | 4 studies | 27% ± 7% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
|---|---|---|---|---|---|---|
| brain | 79% | 386.61 | 2090 / 2642 | 60% | 4.81 | 425 / 705 |
| pancreas | 29% | 22.47 | 95 / 328 | 23% | 1.05 | 41 / 178 |
| adrenal gland | 17% | 16.14 | 43 / 258 | 22% | 3.18 | 50 / 230 |
| uterus | 27% | 49.14 | 46 / 170 | 2% | 0.06 | 7 / 459 |
| adipose | 10% | 13.49 | 122 / 1204 | 0% | 0 | 0 / 0 |
| bladder | 10% | 6.62 | 2 / 21 | 1% | 0.16 | 3 / 504 |
| kidney | 1% | 0.60 | 1 / 89 | 7% | 0.30 | 66 / 901 |
| blood vessel | 7% | 6.51 | 99 / 1335 | 0% | 0 | 0 / 0 |
| intestine | 3% | 2.17 | 33 / 966 | 2% | 0.06 | 8 / 527 |
| prostate | 5% | 7.57 | 12 / 245 | 0% | 0 | 0 / 502 |
| eye | 0% | 0 | 0 / 0 | 3% | 0.10 | 2 / 80 |
| stomach | 2% | 1.16 | 6 / 359 | 1% | 0.02 | 2 / 286 |
| breast | 1% | 0.83 | 5 / 459 | 1% | 0.07 | 10 / 1118 |
| skin | 1% | 1.45 | 20 / 1809 | 0% | 0.03 | 2 / 472 |
| esophagus | 0% | 0.18 | 4 / 1445 | 1% | 0.01 | 2 / 183 |
| lung | 0% | 0.09 | 1 / 578 | 1% | 0.05 | 13 / 1155 |
| thymus | 0% | 0.18 | 2 / 653 | 0% | 0 | 0 / 605 |
| abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| heart | 0% | 0 | 0 / 861 | 0% | 0 | 0 / 0 |
| liver | 0% | 0 | 0 / 226 | 0% | 0 | 0 / 406 |
| lymph node | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 29 |
| muscle | 0% | 0 | 0 / 803 | 0% | 0 | 0 / 0 |
| nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| ovary | 0% | 0 | 0 / 180 | 0% | 0 | 0 / 430 |
| peripheral blood | 0% | 0 | 0 / 929 | 0% | 0 | 0 / 0 |
| placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| spleen | 0% | 0 | 0 / 241 | 0% | 0 | 0 / 0 |
| tonsil | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 45 |
| ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
| GO_0030336 | Biological process | negative regulation of cell migration |
| GO_0008285 | Biological process | negative regulation of cell population proliferation |
| GO_0043065 | Biological process | positive regulation of apoptotic process |
| GO_0090090 | Biological process | negative regulation of canonical Wnt signaling pathway |
| GO_0030308 | Biological process | negative regulation of cell growth |
| GO_0016020 | Cellular component | membrane |
| GO_0005737 | Cellular component | cytoplasm |
| Gene name | TMEM196 |
| Protein name | Transmembrane protein 196 |
| Synonyms | |
| Description | FUNCTION: Acts as a tumor suppressor in lung cancer . Inhibits tumor cell growth by inhibiting cell proliferation and migration and promoting cell apoptosis . Inhibits metastasis of lung cancer by suppressing beta-catenin expression in the Wnt/beta-catenin signaling pathway (By similarity). . |
| Accessions | F8WE15 ENST00000422233.5 ENST00000405764.7 [Q5HYL7-4] ENST00000493519.2 [Q5HYL7-2] B7WNR7 Q5HYL7 ENST00000405844.6 |